Strides Shasun receives USFDA approval for Omega-3-Acid Ethyl Esters capsules

20 Sep 2017 Evaluate

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Omega-3-Acid Ethyl Esters Softgel capsules, a generic version of Lovaza. The US market for the generic Lovaza is approximately $300 million per annum, as per IMS, with five generic players including Par Pharmaceutical (Par), an Endo International Company.

The company has partnered with Par to market the product in the United States. The product to be manufactured in its flagship facility in Bangalore will be launched immediately.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.



Strides Pharma Scien Share Price

864.80 39.45 (4.78%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×